Evaluation of a New Method for Instilling Eye Drops
NCT02697318 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2018-01-23
Summary
The purpose of this project is to demonstrate that there is a new easier method to instill eye drops in ones own eye that is as effective as applying a drop directly to their open eye. The benefits of this new method include better medication compliance and reduced patient anxiety from instilling their eye drops. This secondary benefit should remove the "approach-avoidance response" that prompts some patients to delay or give-up on instilling their drops just to avoid the angst and frustration produced by the challenge.
The new method involves the patient instilling the eye drop onto their closed eyelid and then blinking the eye drop into their eye. We aim to show that this method has a similar therapeutic effect as the routine administration of an eye drop to an open eye.
Conditions
- Ophthalmic Solutions
- Glaucoma
Interventions
- DRUG
-
Timolol maleate 0.5% ophthalmic solution
Sponsors & Collaborators
-
University of Waterloo
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-05-31
- Primary Completion
- 2017-09-30
- Completion
- 2018-01-07
Countries
- Canada
Study Locations
More Related Trials
-
Handheld Vibrator Versus Topical Eye Drops as Anesthesia for Intravitreal Injections
NCT03079713 ·Status: COMPLETED ·Phase: NA
-
Cross-Over Evaluation of Two Lubricating Eye Drops
NCT00493662 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Investigation of Visual Acuity in Contact Lens Wearers After Instillation of a Lipid- Based Lubricating Eye Drop
NCT06131476 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Patient Comfort After Two Anesthetic Protocols for Injections Into the Eye
NCT01087489 ·Status: COMPLETED ·Phase: NA
-
Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections
NCT02951351 ·Status: COMPLETED ·Phase: NA
-
Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients: Trough Drug Effects
NCT00469690 ·Status: COMPLETED ·Phase: PHASE4
-
An Evaluation of the Safety and Efficacy of FID 114657
NCT01030237 ·Status: COMPLETED ·Phase: NA
-
Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients
NCT00347503 ·Status: COMPLETED ·Phase: PHASE4
-
Cool vs Room-temperature Artificial Tears
NCT05832996 ·Status: COMPLETED ·Phase: PHASE4
-
Lubricating Eye Drops After Routine Cataract Surgery
NCT04465071 ·Status: COMPLETED ·Phase: NA
-
Brimonidine for Subconjunctival Hemorrhage From Femtosecond Laser Assisted Cataract Surgery
NCT04633954 ·Status: COMPLETED ·Phase: NA
-
Effect of Prophylactic Ketorolac on CME After Cataract Surgery
NCT00335439 ·Status: COMPLETED ·Phase: NA
-
Observation on the Herpes Simplex Keratitis
NCT03013959 ·Status: UNKNOWN
-
A Prospective Study to Evaluate the Raindrop Near Vision Inlay With Mitomycin C
NCT03242317 ·Status: UNKNOWN ·Phase: PHASE4
-
A Multi-Center, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of AC-170 Ophthalmic Solution
NCT02756624 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Necessity of Anti-inflammatory Drops After Laser Peripheral Iridotomy
NCT02955641 ·Status: UNKNOWN ·Phase: NA
-
Modified Intraocular Lens to Reduce Eye Inflammation After Cataract Surgery in Uveitis Patients
NCT00001311 ·Status: COMPLETED ·Phase: PHASE2
-
Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase
NCT00520260 ·Status: COMPLETED ·Phase: PHASE4
-
Patient Assessment of Topical Anesthetic Effectiveness for Intravitreal Injections
NCT01027611 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Topical Nepafenac 0.1% on Pain Related to Intravitreal Injections
NCT02821390 ·Status: COMPLETED ·Phase: NA
-
Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution
NCT05938699 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Subconjunctival Injection of Local Anesthetic in Anterior Blepharoptosis Repair
NCT02959697 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery
NCT00703781 ·Status: COMPLETED ·Phase: PHASE3
-
Post Intravitreal Injection Topical NSAID vs. Patching
NCT03918590 ·Status: UNKNOWN ·Phase: PHASE4
-
No Drop Post-Op Cataract Surgery
NCT03864133 ·Status: COMPLETED ·Phase: PHASE4